Press Releases Keyword Search Year None20232022202120202019201820172016201520142013 February 15, 2023 Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2022 Results and Corporate Update January 19, 2023 Editas Medicine and Shoreline Biosciences Enter into Definitive Agreement for Shoreline to Acquire Editas’ iNK Cell Franchise and Related Gene Editing Technologies January 9, 2023 Editas Medicine Announces Strategic Updates and Portfolio Reprioritization January 4, 2023 Editas Medicine to Present at the 41st Annual J.P. Morgan Healthcare Conference Pagination First page « first Previous page ‹ previous Page 1 Current page 2
February 15, 2023 Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2022 Results and Corporate Update
January 19, 2023 Editas Medicine and Shoreline Biosciences Enter into Definitive Agreement for Shoreline to Acquire Editas’ iNK Cell Franchise and Related Gene Editing Technologies
